1. Home
  2. RNAC vs GDEV Comparison

RNAC vs GDEV Comparison

Compare RNAC & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAC
  • GDEV
  • Stock Information
  • Founded
  • RNAC 2007
  • GDEV 2009
  • Country
  • RNAC United States
  • GDEV Cyprus
  • Employees
  • RNAC N/A
  • GDEV N/A
  • Industry
  • RNAC Biotechnology: Pharmaceutical Preparations
  • GDEV EDP Services
  • Sector
  • RNAC Health Care
  • GDEV Technology
  • Exchange
  • RNAC Nasdaq
  • GDEV Nasdaq
  • Market Cap
  • RNAC 276.3M
  • GDEV 266.7M
  • IPO Year
  • RNAC 2016
  • GDEV N/A
  • Fundamental
  • Price
  • RNAC $10.74
  • GDEV $14.53
  • Analyst Decision
  • RNAC Strong Buy
  • GDEV Buy
  • Analyst Count
  • RNAC 4
  • GDEV 1
  • Target Price
  • RNAC $40.00
  • GDEV $70.00
  • AVG Volume (30 Days)
  • RNAC 48.0K
  • GDEV 5.3K
  • Earning Date
  • RNAC 11-06-2025
  • GDEV 09-02-2025
  • Dividend Yield
  • RNAC N/A
  • GDEV N/A
  • EPS Growth
  • RNAC N/A
  • GDEV 12.96
  • EPS
  • RNAC N/A
  • GDEV 2.56
  • Revenue
  • RNAC $1,026,000.00
  • GDEV $425,112,000.00
  • Revenue This Year
  • RNAC N/A
  • GDEV N/A
  • Revenue Next Year
  • RNAC N/A
  • GDEV $11.69
  • P/E Ratio
  • RNAC N/A
  • GDEV $5.68
  • Revenue Growth
  • RNAC N/A
  • GDEV N/A
  • 52 Week Low
  • RNAC $8.46
  • GDEV $8.60
  • 52 Week High
  • RNAC $26.50
  • GDEV $42.76
  • Technical
  • Relative Strength Index (RSI)
  • RNAC 47.06
  • GDEV 50.66
  • Support Level
  • RNAC $9.85
  • GDEV $11.25
  • Resistance Level
  • RNAC $10.83
  • GDEV $17.00
  • Average True Range (ATR)
  • RNAC 0.51
  • GDEV 1.01
  • MACD
  • RNAC 0.00
  • GDEV 0.27
  • Stochastic Oscillator
  • RNAC 49.52
  • GDEV 57.04

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

About GDEV GDEV Inc.

GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.

Share on Social Networks: